CASC

Cascadian Therapeutics, Inc.
CASC

Delisted

CASC was delisted on the 8th of March, 2018.

57 hedge funds and large institutions have $63.3M invested in Cascadian Therapeutics, Inc. in 2016 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 31 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$625K
Puts
$86K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$18M
2
$13.5M
3
$7.72M
4
$4.8M
5
$3.97M
6
$2.83M
7
$2.35M
8
$2.34M
9
$1.33M
10
$988K
11
$925K
12
$766K
13
$526K
14
$498K
15
$362K
16
$206K
17
$203K
18
$200K
19
$195K
20
$148K
21
$122K
22
$121K
23
$120K
24
$114K
25
$111K